Statements (62)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:historical_events
|
| gptkbp:case_analysis |
pharmaceutical regulation
risk management in healthcare |
| gptkbp:caused_by |
Thalidomide drug
|
| gptkbp:has_a_focus_on |
research studies
|
| gptkbp:has_influenced |
public health policies
international drug regulations the development of new regulations |
| gptkbp:has_led_to |
improvements in prenatal care
improved patient advocacy efforts greater public awareness of drug risks greater scrutiny of clinical trials support groups for affected individuals |
| gptkbp:highlights |
drug safety issues
|
| https://www.w3.org/2000/01/rdf-schema#label |
Thalidomide tragedy
|
| gptkbp:influenced |
medical ethics
|
| gptkbp:inspired |
advocacy for disability rights
|
| gptkbp:investigates |
government agencies
|
| gptkbp:involved |
gptkb:Australia
gptkb:Canada gptkb:Germany gptkb:United_Kingdom gptkb:United_States clinical trials pharmaceutical companies phocomelia |
| gptkbp:is_a_reminder_of |
the importance of informed consent
|
| gptkbp:is_a_subject_of |
gptkb:books
gptkb:documentaries artistic expression medical ethics debates |
| gptkbp:is_affected_by |
thousands of children
|
| gptkbp:is_associated_with |
teratogenic effects
|
| gptkbp:is_cited_in |
discussions of drug safety
|
| gptkbp:is_linked_to |
maternal health issues
|
| gptkbp:is_often_discussed_in |
bioethics forums
|
| gptkbp:is_often_referenced_in |
legal discussions about liability
|
| gptkbp:is_often_used_in |
the need for thorough testing
|
| gptkbp:is_part_of |
medical ethics curriculum
medical sociology studies |
| gptkbp:is_referenced_in |
gptkb:popular_culture
|
| gptkbp:is_remembered_for |
ethical implications
|
| gptkbp:is_studied_in |
pharmacology courses
|
| gptkbp:key_event |
the history of pharmaceuticals
|
| gptkbp:led_to |
regulatory changes in drug approval
Thalidomide being banned increased scrutiny of drug testing |
| gptkbp:narrative |
drug development practices
|
| gptkbp:notable_case |
toxicology
|
| gptkbp:notable_examples |
corporate responsibility
|
| gptkbp:occurs_in |
1960s
|
| gptkbp:prompted |
changes in pharmaceutical law
|
| gptkbp:resulted_in |
awareness campaigns
birth defects lawsuits against manufacturers enhanced patient safety measures increased funding for drug safety research |
| gptkbp:significant_event |
medical history
pharmaceutical ethics. |
| gptkbp:bfsParent |
gptkb:Federal_Food,_Drug,_and_Cosmetic_Act
gptkb:Food,_Drug,_and_Cosmetic_Act |
| gptkbp:bfsLayer |
5
|